Nucleate is excited to announce that the application deadline for the Eli Lilly and Company Grand Challenge 2024 has been extended until July 29th, 2024! Selected semi-finalists will visit Lilly HQ, network with top executives and scientists, and pitch on stage for the $100K non-dilutive grant award. We will host a third virtual information session on July 22, 2024 to answer all your last minute questions!
We encourage applications in therapeutics, diagnostics, discovery platforms, and delivery, especially in areas like neurodegeneration, pain, neuropathy, epilepsy, psychiatry, sensory disorders, and regenerative medicine. Affiliation with Nucleate is not required. Don’t miss this incredible opportunity and apply today!
Register for the info session: https://lu.ma/6pr5ieuj
Submit your application: https://lnkd.in/gxPq27xe